Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.